Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897069-23-001093
Filing Date
2023-08-04
Accepted
2023-08-04 16:41:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 tm41.htm SC 13G/A 48960
  Complete submission text file 0000897069-23-001093.txt   50555
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Filed by) CIK: 0001797409 (see all company filings)

EIN.: 842985609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92222 | Film No.: 231144585
SIC: 2834 Pharmaceutical Preparations